Life Sciences

The days of blockbuster drugs, lofty revenues and regulatory clarity are gone. Is your organization prepared to implement the tools, processes and operational strategy required to survive, and even grow, over the next five years?

  • The new and improved retail pharmacy experience

    Industry: Life Sciences, Retail
    Capability: Operations Excellence

    West Monroe Partners helped a large pharmacy chain redesign the way its pharmacy conducted business to remain competitive in the market. Lengthy wait times were hurting the customer experience and inefficient processes were costing a fortune. Without the capital to invest in a major overhaul of its infrastructure or new technology, the client was skeptical that it could achieve any meaningful improvements.


    This article summarizes the retail pharmacy chain's transformation.

  • As featured in Outsourced Pharma

    Industry: Life Sciences, Private Equity
    Date: May 20, 2014

    For major pharma companies, M&A is the new R&D, says Jim Bedford, director, Life Sciences practice, and John Hurley, director, Private Equity practice.

  • How to set expectations for the 2014 M&A landscape

    Industry: Banking & Credit Unions, Manufacturing & Distribution, Healthcare, Life Sciences, Private Equity
    Capability: Mergers & Acquisitions
    Date: March 13, 2014
    Globally 2013 wasn’t a knockout year for M&A. With just over 36,800 announced deals totaling $2.4 trillion (the slowest period for deal announcements since 2005 and for value since 2009), M&A activity remained somewhat underwhelming. West Monroe Partners took a deeper dive into the 2013 M&A landscape, examining deal stats through a strategic vs. financial buyer lens to figure out why last year played out as it did, and how to set expectations for 2014.
  • By Steve Sapletal as featured in BiotechBlog

    Industry: Life Sciences
    Capability: Mergers & Acquisitions
    Date: February 7, 2014
    Steve Sapletal, director in West Monroe Partners’ Minneapolis office, explains why large medical device companies may want to consider consolidating operations or selling non-strategic parts of their business in order to improve margins and profitability.
  • As featured in the Minneapolis/St. Paul Business Journal

    Industry: Life Sciences
    Capability: Mergers & Acquisitions
    Date: October 2, 2013
    West Monroe Partners acquired On Point Consulting, a Minneapolis-based firm specializing in merger integration solutions. The transaction combines West Monroe’s strength in the private equity segment of the M&A market with On Point’s solutions and expertise in the strategic/corporate buyer market, establishing one of the nation’s premier M&A advisory firms.
  • Industry: Life Sciences
    Capability: Customer Experience
    The client is a research and development-driven global pharmaceutical company. It strives to improve lives through innovative and effective medicines.
  • By Jim Bedford, as featured in Washington Healthcare News

    Industry: Life Sciences
    Capability: Customer Experience, Advanced Analytics
    Date: March 13, 2013
    Jim Bedford, Director of West Monroe's Life Sciences practice, discusses how the market for specialty drugs that provide therapy for certain chronic conditions has accelerated, and in turn, pharmaceutical organizations should focus on increasing patient adherence to capitalize on this growing sector.
  • by Jim Bedford, as featured in Washington Healthcare News

    Industry: Life Sciences
    Capability: Advanced Analytics, Customer Experience
    Jim Bedford, Director of West Monroe's Life Sciences practice, discusses how the market for specialty drugs that provide therapy for certain chronic conditions has accelerated, and in turn, pharmaceutical organizations should focus on increasing patient adherence to capitalize on this growing sector.
  • Worry-Free Support for Routine Needs; Insight and Proactive advice

    Industry: Life Sciences
    Capability: Managed Services
    West Monroe Partners provides skilled technology resources, as well as a team with years of experience helping biotechnology companies develop and maintain the IT infrastructure critical to addressing their goals. 
  • Personalized medicine or personalized marketing?

    Industry: Life Sciences
    Capability: Customer Experience, Advanced Analytics
    Combined life sciences industry experience with business intelligence, technology, and customer experience expertise—creates advanced capabilities for specialty drugs.
Looking for a place where you can do your best work? Careers at WMP